Inventor · disambiguated record
Hirotaka Kurebayashi
Also filed as: KUREBAYASHI HIROTAKA
8 granted patents·2 pending applications·51 citations·filing 2010–2024
84Inventor score
Files withSUMITOMO DAINIPPON PHARMA CO LTD4SUMITOMO PHARMA ONCOLOGY INC3DAINIPPON SUMITOMO PHARMA CO1SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1SUMITOMO PHARMA CO LTD1
Top patents by PatentIndex Score
10 records- 0195US11530231B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2021·Granted Dec 20, 2022·5 cites·21 claims
- 0294US9376398B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2013·Granted Jun 28, 2016·35 cites·30 claims
- 0393US11034710B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2019·Granted Jun 15, 2021·7 cites·28 claims
- 0484US10150743B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2016·Granted Dec 11, 2018·4 cites·19 claims
- 0579US12077510B2Carboxylic acid compoundsSUMITOMO PHARMA CO LTD·Filed 2022·Granted Sep 3, 2024·0 cites·4 claims
- 0679US2025197432A1CDK9 Inhibitors and Polymorphs Thereof For Use As Agents For Treatment of CancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2024·Application pending·0 cites
- 0776US12077554B2CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancerSUMITOMO PHARMA ONCOLOGY INC·Filed 2022·Granted Sep 3, 2024·0 cites·20 claims
- 0865US11299465B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Granted Apr 12, 2022·0 cites·18 claims
- 0965US10562861B2Carboxylic acid compoundsSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2018·Granted Feb 18, 2020·0 cites·13 claims
- 1036US2011136801A1Novel CompoundsDAINIPPON SUMITOMO PHARMA CO·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hirotaka Kurebayashi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →